Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

Paydas, SEMRA

doi:10.1093/annonc/mdw193

Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

Atıf İçin Kopyala

Paydas S.

ANNALS OF ONCOLOGY, cilt.27, sa.8, ss.1650-1651, 2016 (SCI-Expanded)

Yayın Türü: Makale / Kısa Makale
Cilt numarası: 27 Sayı: 8
Basım Tarihi: 2016
Doi Numarası: 10.1093/annonc/mdw193
Dergi Adı: ANNALS OF ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1650-1651
Çukurova Üniversitesi Adresli: Evet

Özet

Granulomatous reaction developing after immunotherapy must not be named as sarcoidosis, post-immunotherapy granulomatous reaction is more approprite in cases receiving immunotherapy.